Report Detail

Other Global NGS Based Diagnostics Market Size, Status and Forecast 2019-2025

  • RnM3411675
  • |
  • 08 July, 2020
  • |
  • Global
  • |
  • 92 Pages
  • |
  • QYResearch
  • |
  • Other

NGS Based Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NGS Based Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Janssen
Roche
Qiagen
ThermoFisher Scientific
Oxford Gene Technology
Illumina
Pacific Biosciences
Paradigm Diagnostics
Innogene Kalbiotech
Admera Health
AITbiotech
Centogene
Phalanx Biotech Group
iGenomX

Market segment by Type, the product can be split into
DNA Sequencing
RNA Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Other
Market segment by Application, split into
Hospitals
Clinics
Academics/Research Institutions

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by NGS Based Diagnostics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global NGS Based Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 DNA Sequencing
    • 1.4.3 RNA Sequencing
    • 1.4.4 Whole Genome Sequencing
    • 1.4.5 Whole Exome Sequencing
    • 1.4.6 Other
  • 1.5 Market by Application
    • 1.5.1 Global NGS Based Diagnostics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Academics/Research Institutions
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global NGS Based Diagnostics Market Perspective (2015-2026)
  • 2.2 Global NGS Based Diagnostics Growth Trends by Regions
    • 2.2.1 NGS Based Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 NGS Based Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 NGS Based Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 NGS Based Diagnostics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key NGS Based Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top NGS Based Diagnostics Players by Market Size
    • 3.1.1 Global Top NGS Based Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global NGS Based Diagnostics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global NGS Based Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global NGS Based Diagnostics Market Concentration Ratio
    • 3.2.1 Global NGS Based Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by NGS Based Diagnostics Revenue in 2019
  • 3.3 NGS Based Diagnostics Key Players Head office and Area Served
  • 3.4 Key Players NGS Based Diagnostics Product Solution and Service
  • 3.5 Date of Enter into NGS Based Diagnostics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global NGS Based Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global NGS Based Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global NGS Based Diagnostics Market Size by Application (2015-2020)
  • 5.2 Global NGS Based Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America NGS Based Diagnostics Market Size (2015-2020)
  • 6.2 NGS Based Diagnostics Key Players in North America (2019-2020)
  • 6.3 North America NGS Based Diagnostics Market Size by Type (2015-2020)
  • 6.4 North America NGS Based Diagnostics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe NGS Based Diagnostics Market Size (2015-2020)
  • 7.2 NGS Based Diagnostics Key Players in Europe (2019-2020)
  • 7.3 Europe NGS Based Diagnostics Market Size by Type (2015-2020)
  • 7.4 Europe NGS Based Diagnostics Market Size by Application (2015-2020)

8 China

  • 8.1 China NGS Based Diagnostics Market Size (2015-2020)
  • 8.2 NGS Based Diagnostics Key Players in China (2019-2020)
  • 8.3 China NGS Based Diagnostics Market Size by Type (2015-2020)
  • 8.4 China NGS Based Diagnostics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan NGS Based Diagnostics Market Size (2015-2020)
  • 9.2 NGS Based Diagnostics Key Players in Japan (2019-2020)
  • 9.3 Japan NGS Based Diagnostics Market Size by Type (2015-2020)
  • 9.4 Japan NGS Based Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia NGS Based Diagnostics Market Size (2015-2020)
  • 10.2 NGS Based Diagnostics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia NGS Based Diagnostics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia NGS Based Diagnostics Market Size by Application (2015-2020)

11 India

  • 11.1 India NGS Based Diagnostics Market Size (2015-2020)
  • 11.2 NGS Based Diagnostics Key Players in India (2019-2020)
  • 11.3 India NGS Based Diagnostics Market Size by Type (2015-2020)
  • 11.4 India NGS Based Diagnostics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America NGS Based Diagnostics Market Size (2015-2020)
  • 12.2 NGS Based Diagnostics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America NGS Based Diagnostics Market Size by Type (2015-2020)
  • 12.4 Central & South America NGS Based Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Janssen
    • 13.1.1 Janssen Company Details
    • 13.1.2 Janssen Business Overview
    • 13.1.3 Janssen NGS Based Diagnostics Introduction
    • 13.1.4 Janssen Revenue in NGS Based Diagnostics Business (2015-2020))
    • 13.1.5 Janssen Recent Development
  • 13.2 Roche
    • 13.2.1 Roche Company Details
    • 13.2.2 Roche Business Overview
    • 13.2.3 Roche NGS Based Diagnostics Introduction
    • 13.2.4 Roche Revenue in NGS Based Diagnostics Business (2015-2020)
    • 13.2.5 Roche Recent Development
  • 13.3 Qiagen
    • 13.3.1 Qiagen Company Details
    • 13.3.2 Qiagen Business Overview
    • 13.3.3 Qiagen NGS Based Diagnostics Introduction
    • 13.3.4 Qiagen Revenue in NGS Based Diagnostics Business (2015-2020)
    • 13.3.5 Qiagen Recent Development
  • 13.4 ThermoFisher Scientific
    • 13.4.1 ThermoFisher Scientific Company Details
    • 13.4.2 ThermoFisher Scientific Business Overview
    • 13.4.3 ThermoFisher Scientific NGS Based Diagnostics Introduction
    • 13.4.4 ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2015-2020)
    • 13.4.5 ThermoFisher Scientific Recent Development
  • 13.5 Oxford Gene Technology
    • 13.5.1 Oxford Gene Technology Company Details
    • 13.5.2 Oxford Gene Technology Business Overview
    • 13.5.3 Oxford Gene Technology NGS Based Diagnostics Introduction
    • 13.5.4 Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2015-2020)
    • 13.5.5 Oxford Gene Technology Recent Development
  • 13.6 Illumina
    • 13.6.1 Illumina Company Details
    • 13.6.2 Illumina Business Overview
    • 13.6.3 Illumina NGS Based Diagnostics Introduction
    • 13.6.4 Illumina Revenue in NGS Based Diagnostics Business (2015-2020)
    • 13.6.5 Illumina Recent Development
  • 13.7 Pacific Biosciences
    • 13.7.1 Pacific Biosciences Company Details
    • 13.7.2 Pacific Biosciences Business Overview
    • 13.7.3 Pacific Biosciences NGS Based Diagnostics Introduction
    • 13.7.4 Pacific Biosciences Revenue in NGS Based Diagnostics Business (2015-2020)
    • 13.7.5 Pacific Biosciences Recent Development
  • 13.8 Paradigm Diagnostics
    • 13.8.1 Paradigm Diagnostics Company Details
    • 13.8.2 Paradigm Diagnostics Business Overview
    • 13.8.3 Paradigm Diagnostics NGS Based Diagnostics Introduction
    • 13.8.4 Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2015-2020)
    • 13.8.5 Paradigm Diagnostics Recent Development
  • 13.9 Innogene Kalbiotech
    • 13.9.1 Innogene Kalbiotech Company Details
    • 13.9.2 Innogene Kalbiotech Business Overview
    • 13.9.3 Innogene Kalbiotech NGS Based Diagnostics Introduction
    • 13.9.4 Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2015-2020)
    • 13.9.5 Innogene Kalbiotech Recent Development
  • 13.10 Admera Health
    • 13.10.1 Admera Health Company Details
    • 13.10.2 Admera Health Business Overview
    • 13.10.3 Admera Health NGS Based Diagnostics Introduction
    • 13.10.4 Admera Health Revenue in NGS Based Diagnostics Business (2015-2020)
    • 13.10.5 Admera Health Recent Development
  • 13.11 AITbiotech
    • 10.11.1 AITbiotech Company Details
    • 10.11.2 AITbiotech Business Overview
    • 10.11.3 AITbiotech NGS Based Diagnostics Introduction
    • 10.11.4 AITbiotech Revenue in NGS Based Diagnostics Business (2015-2020)
    • 10.11.5 AITbiotech Recent Development
  • 13.12 Centogene
    • 10.12.1 Centogene Company Details
    • 10.12.2 Centogene Business Overview
    • 10.12.3 Centogene NGS Based Diagnostics Introduction
    • 10.12.4 Centogene Revenue in NGS Based Diagnostics Business (2015-2020)
    • 10.12.5 Centogene Recent Development
  • 13.13 Phalanx Biotech Group
    • 10.13.1 Phalanx Biotech Group Company Details
    • 10.13.2 Phalanx Biotech Group Business Overview
    • 10.13.3 Phalanx Biotech Group NGS Based Diagnostics Introduction
    • 10.13.4 Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2015-2020)
    • 10.13.5 Phalanx Biotech Group Recent Development
  • 13.14 iGenomX
    • 10.14.1 iGenomX Company Details
    • 10.14.2 iGenomX Business Overview
    • 10.14.3 iGenomX NGS Based Diagnostics Introduction
    • 10.14.4 iGenomX Revenue in NGS Based Diagnostics Business (2015-2020)
    • 10.14.5 iGenomX Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on NGS Based Diagnostics. Industry analysis & Market Report on NGS Based Diagnostics is a syndicated market report, published as Global NGS Based Diagnostics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of NGS Based Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,061.50
    4,592.25
    6,123.00
    3,595.80
    5,393.70
    7,191.60
    612,261.00
    918,391.50
    1,224,522.00
    324,129.00
    486,193.50
    648,258.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report